imipramine has been researched along with arachidonic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Dragan, YP; Ellis, EF | 1 |
| Barkai, AI; Murthy, LR | 1 |
| Cittadini, A; Corda, D; Covacci, V; Di Francesco, A; Wolf, FI | 1 |
| Bruzzese, N; Cittadini, A; Corda, D; Covacci, V; Di Francesco, A; Sacchetti, A; Wolf, FI | 1 |
| Chang, L; Kim, HW; Lee, HJ; Rao, JS; Rapoport, SI | 1 |
| Panczyszyn-Trzewik, P; Rzezniczek X, S; Sowa-Kucma, M; Stachowicz, K | 1 |
7 other study(ies) available for imipramine and arachidonic acid
| Article | Year |
|---|---|
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
5-Hydroxytryptamine and the metabolism of arachidonic acid by the lipoxygenase and cyclooxygenase of washed human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Humans; Hydroxyeicosatetraenoic Acids; Imipramine; In Vitro Techniques; Lipoxygenase; Prostaglandin-Endoperoxide Synthases; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes | 1990 |
Modulation of arachidonate turnover in cerebral phospholipids.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cerebral Cortex; Desipramine; Imipramine; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Norepinephrine; Phospholipids; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Regulation of intracellular magnesium in ascites cells: involvement of different regulatory pathways.
Topics: Adenosine Triphosphate; Adrenergic Uptake Inhibitors; Animals; Antiporters; Arachidonic Acid; Biological Transport; Carcinoma, Ehrlich Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Cytoplasm; Imipramine; Indomethacin; Magnesium; Mice; Signal Transduction | 1996 |
Differentiation of HL-60 promyelocytic leukemia cells is accompanied by a modification of magnesium homeostasis.
Topics: Adenosine Triphosphate; Alprostadil; Antiporters; Arachidonic Acid; Bucladesine; Calcimycin; Calcium; Cell Differentiation; Cell Membrane Permeability; Choline; Colforsin; Digitonin; Dimethyl Sulfoxide; HL-60 Cells; Homeostasis; Humans; Imipramine; Interferon-alpha; Magnesium; Neutrophils; Rotenone | 1998 |
Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?
Topics: Animals; Arachidonic Acid; Bipolar Disorder; Bupropion; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Drug Administration Schedule; Frontal Lobe; Humans; Imipramine; Male; Phospholipases A2, Calcium-Independent; Phospholipases A2, Cytosolic; Phosphorylation; Rats; Signal Transduction; Transcription Factor AP-2; Up-Regulation | 2010 |
Cyclooxygenase-2 inhibition affects the expression of down syndrom cell adhesion molecule via interaction with metabotropic glutamate receptor 5.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arachidonic Acid; Cell Adhesion; Cell Adhesion Molecules; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Depressive Disorder, Major; Imipramine; Mice; Mice, Inbred C57BL; Nitrobenzenes; Pyridines; Receptor, Metabotropic Glutamate 5; RNA, Messenger; Sulfonamides; Thiazoles | 2022 |